Niraparib Tosylate | Interleukin Related interleukin-related.com

Product Name :
Niraparib Tosylate

Search keywords :
Niraparib

drugId :
null

Target Vo:
Poly (ADP-Ribose) Polymerase 2

Target Vo Short Name :
PARP-2

Moa_Name:
Poly (ADP-Ribose) polymerase 1 inhibitors

First Approval Country :
United States

First Approval Date Filter:
2017

Origin Company_Name :
Tesaro Inc

Active Company_Name :
Almac Clinical Services

Active Indication_Name:
Ovarian Neoplasms

In Active Indication_Name:
Leukemia, Prolymphocytic, T-Cell

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Anselamimab Purity
Lokivetmab Purity & Documentation
S100B Antibody: S100B Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 11 kDa, targeting to S100B. It can be used for WB,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat, Goat.

Author: Interleukin Related

Related Posts